SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (18916)2/18/1999 9:54:00 PM
From: Barry P. Sullivan  Read Replies (1) | Respond to of 23519
 
Here's the First Call estimate as of 2/13/99. Doesn't say who the lone analyst is.

First Call Earnings Estimates for Vivus Inc.

First Call Consensus Earnings Estimates as of 02/13/99
Latest Price: 2.44 Industry:Med & Bio Tech FYE:Dec 98 Consensus Recommendation:Buy

Vivus Inc.
NASDAQ:VVUS
Next Quarter Mar 99 EPS .01, Report Date Apr 09.
Fiscal Year Dec 99 EPS .20.
Number of Brokers 1.
Long Term Growth Rate: 18%.
1999 Price/Earnings Ratio: 12.